Search Results

1 - 10 of 277 items :

  • pharmacokinetics x
  • Clinical Medicine x
Clear All
Pharmacokinetics of cytisine after single intravenous and oral administration in rabbits

derivatives and of bioisosteric thiocytisine as potent and selective nAChR ligands. Eur J Med Chem   36 : 375-388. Jorenby D, Hays J, Rigotti N, Azoulay S, Watsky E, Williams K, Billing C, Gong J and Reeves K. (2006). Efficacy of varenicline, an α 4 β 2 -nicotinic acetylcholine receptor partial agonist, vs. placebo or sustained-release bupropion for smoking cessation. A randomized controlled trial. JAMA   296 : 56-63. Klocking H, Richter M, and Damm G. (1980). Pharmacokinetic studies with 3 Hcytisine. Arch Toxicol

Open access
The Statistical Analysis of Pharmacokinetic Parameters in the Context of Bioequivalence Testing of Two Anthelmintic Formulas Based on Ivermectine and Triclabendazole in Sheep

References 1. Barrera B, Otero JA, Egido E et al. The Anthelmintic Triclabendazole and Its Metabolites Inhibit the Membrane Transporter ABCG2/BCRP. Antimicrob Agents Chemother 2012; 56(7): 3535-3543. 2. Halferty L, Brennan GP, Trudgett A, Hoey L, Fairweather I. Relative activity of triclabendazole metabolites against the liver fluke, Fasciola hepatica. Vet Parasitol 2009; 159:126–138. 3. González Canga A, Sahagún Prieto AM, José Diez Liébana M, Martínez NF, Vega MS, Vieitez JJ. The pharmacokinetics and metabolism of ivermectin in domestic animal

Open access
Pharmacokinetics Of Zinc In Broiler Chickens After Single Intraingluvial Administration With Zinc Aspartate

.0. Pharmacokinetic and Pharmacodynamic Data Analysis System for PC. Stuttgart, Jena, New York: Gustav Fisher; 1993. 18. Baggot DJ. The Physiological Basis of Veterinary Clinical Pharmacology. Oxford (UK): Blackwell Science Ltd; 2001. 19. Gibaldi M, Perrier D. Pharmacokinetics, Revised and Expanded. 2nd ed. Swarbrick J, editor. New York: Informa Healthcare Inc; 2007. 20. Yamaoka K, Nakagawa T, Uno T. Application of Akaike’s Information Criterion (AIC) in the evaluation of linear pharmacokinetic equations. J Pharmacokinet Biopharm. 1978;6:166-75. 21. Ivanova

Open access
The Influence of CYP2D6 Phenotype on the Pharmacokinetic Profile of Atomoxetine in Caucasian Healthy Subjects

References 1. Corman SL, Fedutes BA, Culley CM. Atomoxetine: the first nonstimulant for the management of attention-deficit/hyperactivity disorder. Am J Health Syst Pharm. 2004;61(22):2391-99. 2. B Barton J. Atomoxetine: a new pharmacotherapeutic approach in the management of attention deficit/hyperactivity disorder. Arch Dis Child. 2005;90 Suppl 1:i26-9. 3. Sauer J-M, Ring BJ, Witcher JW. Clinical pharmacokinetics of atomoxetine. Clin Pharmacokinet. 2005;44(6):571-90. 4. Findling RL. Evolution

Open access
Changes in Some Pharmacokinetics Parameters of Chloroquine by Gnetum Africana

chloroquine sulphate and aqueous extract of Azadirachta indica A Juss (Meliaceae) in rabbits. Acta Pharmaceutica. 2003;53(4):305-11. 8. O’Brien D, Haddad AR. Consulting patients on drug-food interactions. U. S. Pharmacist. 2002;22(6). 9. Eseyin OA, Edoho EJ, Igboasoiyi AC, Nwadiukwu E, Ekpo A. Effects of the leaf extract of Telfairia occidentalis on the pharmacokinetic of chloroquine. International Journal of Biological Chemistry. 2007;1(4):256-260. 10. Igboasoiyi AC, Eseyin OA, Udoma NF. The effect of ethanolic extract of

Open access
Pharmacokinetics of penicillin antibiotics: intravenous-to-oral switch therapy

-606. Kim MK, Capitano B, Mattoes HM, Xuan D, Quintiliani R, Nightingale CH, et al. Pharmacokinetic and Pharmacodynamic Evaluation of Two Dosing Regimens for Piperacillin-Tazobactam. Pharmacotherapy 2007; 22: 569-77. Božidar V. Farmakoterapijski priručnik (5. izdaja). Medicinska naklada Zagreb, 2007. Posamezni povzetki glavnih značilnosti zdravil (SmPC). V: Baza podatkov o zdravilih. Upravljalec: Javna agencija RS za zdravila in medicinske pripomočke. Pridobljeno 11.12.2009 s spletne strani: http

Open access
Effect of Food on the Pharmacokinetics of Gliclazide 60 mg Modified Release Tablet in Healthy Caucasian Volunteers

, Lewis BC, et al. Identification of the human cytochromes P450 catalyzing the rate-limiting pathways of gliclazide elimination. Br J Clin Pharmacol. 2007;64(4):450-7. 15. Todor I, Muntean D, Neag M, et al. The influence of CYP2D6 phenotype on the pharmacokinetic profile of atomoxetine in Caucasian healthy subjects. Acta Medica Marisiensis. 2017;63(2):73-9. 16. Rojanasthien N, Autsavakitipong T, Kumsorn B, et al. Bioequivalence study of modified-release Gliclazide tablets in healthy volunteers. ISRN Pharmacol. 2012;2012. doi:10.5402/2012/375134. 17

Open access
The Monitoring of Immunosuppressive Therapy with Tacrolimus in Patients with Kidney Transplant, Based on the Pharmacokinetic Criteria

transplantation. Prilozi 2011;32:87-103. 12. Naesens M, Kuypers DRJ, Sarwal M. Calcineurin inhibitor nephrotoxicity. Clin J Am Soc Nephrol 2009;4:481–508. 13. Michael F. Crutchlow, Roy D. Bloom. Transplant-associated hyperglycemia: A new look at an old problem.Clin J Am Soc Nephrol 2007;2:343–355. 14. Pirsch J, Bekersky I, Vincenti F et al. Coadministration of tacrolimus and mycophenolate mofetil in stable kidney transplant patients: pharmacokinetics and tolerability. J Clin Pharmacol 2000;40:527-532. 15. Hasselink DA, Ngyuen H, Wabbijin M et al

Open access
The progress in study of fosfomycin

, phosphonomycin amino butyl alcohol three salt granules, and fosfomycin two sodium salt for injection. Although the clinical application of phosphomycin has increased in recent years, there are few clinical reports in China. According to the related literatures at home and abroad, this review briefly introduces fosfomycin in the following three aspects: progress in synthetic methods, pharmacokinetic and pharmacodynamic characteristics, and antibacterial activities, to provide references for clinical rational use. 2 The synthesis of fosfomycin Fosfomycin was first

Open access
Bioequivalence of indinavir capsules in healthy volunteers

. Single-dose pharmacokinetics of indinavir and the effect of food. Antimicrob Agents Chemother. 1998; 42:332-8. 5. Hsu A, Granneman GR, Cao G, Carothers L, Japour A, El-Shourbagy T, et al. Pharmacokinetic interaction between ritonavir and indinavir in healthy volunteers. Antimicrob Agents Chemother. 1998; 42:2784-91. 6. The United States Pharmacopoeial Convention, Inc. The United States Pharmacopeia 26 / National Formulary 21. Rockville, USA; 2003. 7. Drug Control Division. Thailand Guidelines for the Conduct of

Open access